Peterborough petition to save lollipop patrols to be considered
The authority said the cuts were "one of a number of difficult decisions" that needed to be made in order to balance the budget.Ms Ambarchian said: "The strength of feeling can be seen in how the petition gathered so many signatures so quickly."We're not sure why the council would take the very real risk that a small child will be injured for what is a relatively minuscule budget saving. "It seems like a dereliction of duty."
'Before tragedy strikes'
Peterborough City Council said crossings and speed restrictions, such at 20mph zones, would be in place at each of the schools, the Local Democracy Reporting Service said. At the full council meeting councillors will be able to either take the action requested, ask its officers to investigate, refer the decision to either cabinet or the relevant scrutiny committee for investigation or note the petition and comments but take no further action.A spokesperson for the petition said: "Let's not wait for a child to be injured or killed before we take action - we call on councillors to do it before tragedy strikes."School crossing patrols are an essential part of ensuring children can safely cross roads, particularly near busy schools and roads with high traffic volumes. "These patrols play a key and proven role in preventing accidents."Angus Ellis, a Labour councillor and cabinet member for environment and transport on the authority, said the council takes the concerns of school pupils and parents "extremely seriously".
Follow Peterborough news on BBC Sounds, Facebook, Instagram and X.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
5 minutes ago
- The Independent
Bank of England chief says ‘not sensible' to tear up ring-fencing rules
The governor of the Bank of England has warned against tearing up the UK's ring-fencing regime, which he said was good for British banks and consumers, after the Government announced plans to reform the system. Andrew Bailey also stressed that the UK cannot 'compromise' on financial stability amid the Treasury's plans to rip up red tape across the sector. Ring-fencing was brought in after the 2008 financial crisis and requires banks to separate their retail services from their investment banking activities. It aimed to protect UK consumers from the effects of any shocks felt by other parts of a bank and in the global financial markets. But Government plans to reforms the rules, unveiled last week, are intended to make Britain more competitive globally and give banks more flexibility. Mr Bailey told MPs on the Treasury Committee: 'I do think the ring-fencing regime is an important part of the structure of the banking system. 'It makes the resolution of banks if they're in trouble much easier, and it benefits, particularly in terms of the UK, consumers, business and households. 'I'm sure there are things that can be improved and we will work constructively to get through that process.' He added: 'I think it has established itself as part of the system and to me it would not be sensible to take it away at this point.' The ring-fencing shake-up formed part of Rachel Reeves's 'Leeds reforms' – a package of measures which she said are set to be the biggest changes to financial services for more than a decade. Ms Reeves said regulation 'still acts as a boot on the neck of businesses' in many areas, and urged regulators to avoid 'excessive caution'. Asked if he agreed with those comments, Bank of England chief Mr Bailey said: 'It's not a term I'd use.' 'I think there are areas that we clearly should look at it… we've announced a whole range of things we're doing, and that's a good thing,' he told the committee. 'But we can't compromise on basic financial stability and that would be my overall message.' However, Mr Bailey added that, post-Brexit, the UK is in a better position to reshape the financial rule book to suit the sector, rather than relying on EU rules.
BreakingNews.ie
6 minutes ago
- BreakingNews.ie
Irish Prison Service urged for halt of extra court sittings and use of garda cells to curb overcrowding
The Irish Prison Service pleaded with the Department of Justice to stop scheduling extra court sittings and to consider using cells in garda stations for prisoners. A message from their director of operations said they had done everything in their power to deal with overcrowding in jails as numbers in custody approached 5,000. Advertisement However, the senior official said they had now run out of options and 'decisions outside of their control' meant the number of people in prison would continue to rise. The email was sent last summer as the Irish Prison Service (IPS) struggled with high levels of overcrowding, which have since deteriorated further. The director of operations – whose name was withheld on security grounds under Freedom of Information laws – said there were 'no easy or palatable decisions' left. He said the UK government had just introduced emergency measures and delayed some court cases due to their own problems with overcrowding. Advertisement The message said there were eight steps that needed to be considered or reconsidered as a 'matter of urgency' to ease pressure on Irish jails. This included: 'Cancellation of scheduled additional court sittings and a commitment that no further additional sittings will be arranged pending prison capacity being addressed.' He also called for the decision to appoint or reassign criminal judges to be reconsidered and that cases involving asylum claims be dealt with in 'alternative facilities.' The director of operations said Ireland should also consider delaying court cases and using garda cells to house prisoners. Advertisement He added: '[We should] reconsider the proposal to unilaterally increase the rate of remission provided for under current legislation.' The email said a new policy on bail was needed urgently to ensure people awaiting trial for 'non-serious offences' were not sent to jail. An eighth suggested measure was redacted from the records on the basis it could compromise the security of the prison system. The email was forwarded to the Department of Justice in May along with an update from the governor of Mountjoy Prison, Ray Murtagh. Advertisement The governor's message said: 'We now have an historical number of 912 prisoners in custody this morning and when I previously expressed concern we were at 858. 'I now have all my additional 114 bunk beds filled and an additional 57 on mattresses.' He said the C base of Mountjoy was at full capacity and that a newly arrived batch of twelve prisoners would also have to sleep on mattresses on the floor. 'We are currently over 120 per cent capacity, and this has placed significant unprecedented pressure on the prison,' wrote Mr Murtagh. Advertisement He added that he could see 'no abatement' in sight and that other prisons in Dublin and Laois were also running over capacity. The records were only released this week by the Irish Prison Service following an appeal under FOI. The number of prisoners in custody has since smashed the 5,000 barrier and, on Monday of this week, reached more than 5,500. That included 588 on temporary release as authorities have sought to ease pressure on a system that is operating at 119 per cent of capacity. Asked about the correspondence, a spokesman said: 'The Irish Prison Service must accept into custody all people committed to prison by the courts. 'As such, the Irish Prison Service has no control over the numbers committed to custody at any given time.' He said temporary release was used on a case-by-case basis and that they were working closely with the Department of Justice to ensure a safe working environment for staff and for prisoners.
Reuters
6 minutes ago
- Reuters
Breakingviews - Big Pharma pioneers the TOFU tariff trade
DUBLIN, July 22 (Reuters Breakingviews) - Big Pharma is giving Donald Trump's credibility a booster shot. Buoyant stock markets generally seem to rest on the belief that the U.S. president always chickens out on provocative trade measures, known as the TACO principle. Yet drugmakers like Britain's $213 billion AstraZeneca (AZN.L), opens new tab, which on Monday revealed a surprisingly solid $50-billion, opens new tab American investment plan, seem to believe that sector-specific tariffs are possible or even likely. Call it the TOFU trade: Trump Occasionally Follows Up. AstraZeneca is not the first pharma company to make a big pledge. In April, opens new tab, only weeks after the now-infamous "Liberation Day" blizzard of trade threats, $260 billion Swiss group Roche (ROG.S), opens new tab also announced a $50-billion U.S. investment plan. That followed American drugmakers Pfizer (PFE.N), opens new tab and Eli Lilly (LLY.N), opens new tab, who had already announced their own chunky commitments to bring more production back home. The investments appear to have an element of damage control. Unlike the S&P 500 Index (.SPX), opens new tab, which is now up 11% since Trump's April 2 tariff announcements and closed at a record level on Monday, investors are offering pharma stocks little chance of immunity. The S&P Pharmaceuticals Select Industry Index is down 1% compared with Liberation Day, while European drugmakers like AstraZeneca, Roche, Novartis (NOVN.S), opens new tab, Sanofi ( opens new tab, GSK (GSK.L), opens new tab and Novo Nordisk ( opens new tab are down 5% to 18%. The falls generally look even more dramatic relative to early February levels, before Trump floated possible tariffs specifically on the sector. AstraZeneca boss Pascal Soriot is making a suitably aggressive bet to soothe investors' fears. His $50 billion pledge is equal to all forecast research and development costs and capital expenditures across 2025, 2026 and 2027, according to Breakingviews calculations using analysts' consensus forecasts gathered by Visible Alpha. Since the United States is only one market, and currently a little over 40% of total revenue, the pledge is undoubtedly a huge number - even if it includes some relabelling of plans that were already underway. Soriot has also made the specific commitment to build a new manufacturing facility in Virginia, which will partly focus on producing ingredients for the racy weight-loss treatment market. True, there's not a huge downside to investing in the largest pharmaceutical market in the world, where drugmakers can often charge 10 times what they can in Europe. Scaling up in the massive U.S. obesity market could pay off over time. On the other hand, analysts told Breakingviews that manufacturing in the United States can be costlier than in Europe because of generally higher staff turnover. Building a new factory also comes with risks. It's hard to argue that Soriot and his rivals would be doing all of this if not for the threat of tariffs. That, of course, could leave Big Pharma with a potential headache if Trump flakes on pharma tariffs, which could be announced as soon as next month. For Soriot and his fellow drugmaker CEOs, it makes sense to hope for TACO but get ready for TOFU. Follow Aimee Donnellan on LinkedIn, opens new tab.
